Roman Fischer
Associate Professor and Head of Discovery Proteomics Facility
In the Discovery Proteomics Facility of the Target Discovery Institute we provide advice in experimental design, sample preparation, sample analysis with state-of-the-art LCMS workflows and data analysis to researchers from Oxford University and national and international collaborators. We routinely use label-free quantitation, SILAC, TMT, SWATH and other methodologies on diverse samples (i.e. cells, tissues, immuno precipitates et al.) and have developed sample preparation techniques to access the deep proteome form little sample amounts using instrumentation such as Orbitrap Fusion Lumos or TimsTOF Pro.
My own interests evolve around clinical proteomics and applications for the spatial characterisation of the proteome in biological structures such as tissues and tumours. In addition, I am developing methodologies for the proteome characterisation of clinical cohort samples at high-throughput.
Recent publications
-
Cyclin F-EXO1 axis controls cell cycle-dependent execution of double-strand break repair.
Journal article
Yang H. et al, (2024), Sci Adv, 10
-
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F Activity.
Preprint
Singh S. et al, (2024)
-
Adaptor protein 2 sigma subunit (AP2S1) variants associated with neurodevelopmental disorders
Preprint
Stevenson M. et al, (2024)
-
Identification of cellular retinoic acid binding protein 2 (CRABP2) as downstream target of nuclear factor I/X (NFIX): implications for skeletal dysplasia syndromes.
Journal article
Kooblall KG. et al, (2024), JBMR Plus, 8
-
Compartmentalization proteomics revealed endolysosomal protein network changes in a goat model of atrial fibrillation.
Journal article
Ayagama T. et al, (2024), iScience, 27